Alessio Fasano: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Katiekay1 (talk | contribs)
No edit summary
Line 20: Line 20:
Throughout his career, he has prioritized and advocated for his patients by disseminating his research to the general public along with expansive outreach efforts. He often collaborates with celiac support organizations and government agencies to work toward this goal, and actively participates in fundraising efforts for the Center for Celiac Research and Treatment. He is the author of multiple books and has been featured in journals, magazines and interviews for the general public<ref>{{Cite web|url=https://hms.harvard.edu/departments/hms-celiac-research-program/people|title=People|website=hms.harvard.edu|language=en|access-date=2020-03-02}}</ref>.
Throughout his career, he has prioritized and advocated for his patients by disseminating his research to the general public along with expansive outreach efforts. He often collaborates with celiac support organizations and government agencies to work toward this goal, and actively participates in fundraising efforts for the Center for Celiac Research and Treatment. He is the author of multiple books and has been featured in journals, magazines and interviews for the general public<ref>{{Cite web|url=https://hms.harvard.edu/departments/hms-celiac-research-program/people|title=People|website=hms.harvard.edu|language=en|access-date=2020-03-02}}</ref>.


He has published numerous groundbreaking research studies, including the 2000 discovery of the zonulin protein and its regulation and modulation of intestinal permeability<ref>{{Cite journal|last=Fasano|first=Alessio|last2=Not|first2=Tarcisio|last3=Wang|first3=Wenle|last4=Uzzau|first4=Sergio|last5=Berti|first5=Irene|last6=Tommasini|first6=Alberto|last7=Goldblum|first7=Simeon E|date=2000-04-29|title=Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease|url=http://www.sciencedirect.com/science/article/pii/S0140673600021693|journal=The Lancet|language=en|volume=355|issue=9214|pages=1518–1519|doi=10.1016/S0140-6736(00)02169-3|issn=0140-6736}}</ref>. In 2003, he published the results of the epidemiological study that demonstrated the prevalence of celiac disease in the U.S. to be far higher than previously thought, at a rate of 1 in 133 persons<ref>{{Cite web|url=https://pubmed.ncbi.nlm.nih.gov/12578508-prevalence-of-celiac-disease-in-at-risk-and-not-at-risk-groups-in-the-united-states-a-large-multicenter-study/|title=Prevalence of Celiac Disease in At-Risk and Not-At-Risk Groups in the United States: A Large Multicenter Study|last=A|first=Fasano|last2=I|first2=Berti|date=2003-02-10|website=Archives of internal medicine|language=en|pmid=12578508|access-date=2020-03-02|last3=T|first3=Gerarduzzi|last4=T|first4=Not|last5=Rb|first5=Colletti|last6=S|first6=Drago|last7=Y|first7=Elitsur|last8=Ph|first8=Green|last9=S|first9=Guandalini}}</ref>. His work also contributed to the development of an anti-tissue transglutaminase (tTG) diagnostic test for celiac disease, that is part of standard diagnostic testing for celiac disease<ref>{{Cite web|url=https://hms.harvard.edu/departments/hms-celiac-research-program/people|title=People|website=hms.harvard.edu|language=en|access-date=2020-03-02}}</ref>.
He has published numerous groundbreaking research studies, including the 2000 discovery of the zonulin protein and its regulation and modulation of intestinal permeability<ref>{{Cite journal|last=Fasano|first=Alessio|last2=Not|first2=Tarcisio|last3=Wang|first3=Wenle|last4=Uzzau|first4=Sergio|last5=Berti|first5=Irene|last6=Tommasini|first6=Alberto|last7=Goldblum|first7=Simeon E|date=2000-04-29|title=Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease|url=http://www.sciencedirect.com/science/article/pii/S0140673600021693|journal=The Lancet|language=en|volume=355|issue=9214|pages=1518–1519|doi=10.1016/S0140-6736(00)02169-3|issn=0140-6736}}</ref>. In 2003, he published the results of the epidemiological study that demonstrated the prevalence of celiac disease in the U.S. to be far higher than previously thought, at a rate of 1 in 133 persons.<ref>{{cite journal |last1=Fasano |first1=Alessio |last2=Berti |first2=Irene |last3=Gerarduzzi |first3=Tania |last4=Not |first4=Tarcisio |last5=Colletti |first5=Richard B. |last6=Drago |first6=Sandro |last7=Elitsur |first7=Yoram |last8=Green |first8=Peter H. R. |last9=Guandalini |first9=Stefano |last10=Hill |first10=Ivor D. |last11=Pietzak |first11=Michelle |last12=Ventura |first12=Alessandro |last13=Thorpe |first13=Mary |last14=Kryszak |first14=Debbie |last15=Fornaroli |first15=Fabiola |last16=Wasserman |first16=Steven S. |last17=Murray |first17=Joseph A. |last18=Horvath |first18=Karoly |title=Prevalence of Celiac Disease in At-Risk and Not-At-Risk Groups in the United States |journal=Archives of Internal Medicine |date=10 February 2003 |volume=163 |issue=3 |pages=286 |doi=10.1001/archinte.163.3.286 |pmid=12578508 }}</ref> His work also contributed to the development of an anti-tissue transglutaminase (tTG) diagnostic test for celiac disease, that is part of standard diagnostic testing for celiac disease.<ref>{{Cite web|url=https://hms.harvard.edu/departments/hms-celiac-research-program/people|title=People|website=hms.harvard.edu|language=en|access-date=2020-03-02}}</ref>


== Awards ==
== Awards ==
Line 116: Line 116:
Fasano has authored (or co-authored) over 300 peer-reviewed publications. Some high-impact publications include:
Fasano has authored (or co-authored) over 300 peer-reviewed publications. Some high-impact publications include:


* Alessio Fasano, Tarcisio Not, Wenle Wang, Sergio Uzzau, Irene Berti, Alberto Tommasini, Simeon E Goldblum. (2000). "Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease." ''The Lancet.'' 355 (9214): 1518-1519. DOI: https://doi.org/10.1016/S0140-6736(00)02169-3.
* {{cite journal |last1=Fasano |first1=Alessio |last2=Not |first2=Tarcisio |last3=Wang |first3=Wenle |last4=Uzzau |first4=Sergio |last5=Berti |first5=Irene |last6=Tommasini |first6=Alberto |last7=Goldblum |first7=Simeon E |title=Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease |journal=The Lancet |date=April 2000 |volume=355 |issue=9214 |pages=1518–1519 |doi=10.1016/S0140-6736(00)02169-3 }}
* Fasano A, Catassi C. (2001). "Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum." ''Gastroenterology''. 120 (3): 636–651. DOI: https://doi.org/10.1053/gast.2001.22123.
* {{cite journal |last1=Fasano |first1=Alessio |last2=Catassi |first2=Carlo |title=Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum |journal=Gastroenterology |date=February 2001 |volume=120 |issue=3 |pages=636–651 |doi=10.1053/gast.2001.22123 }}
* {{cite journal |last1=Fasano |first1=Alessio |last2=Berti |first2=Irene |last3=Gerarduzzi |first3=Tania |last4=Not |first4=Tarcisio |last5=Colletti |first5=Richard B. |last6=Drago |first6=Sandro |last7=Elitsur |first7=Yoram |last8=Green |first8=Peter H. R. |last9=Guandalini |first9=Stefano |last10=Hill |first10=Ivor D. |last11=Pietzak |first11=Michelle |last12=Ventura |first12=Alessandro |last13=Thorpe |first13=Mary |last14=Kryszak |first14=Debbie |last15=Fornaroli |first15=Fabiola |last16=Wasserman |first16=Steven S. |last17=Murray |first17=Joseph A. |last18=Horvath |first18=Karoly |title=Prevalence of Celiac Disease in At-Risk and Not-At-Risk Groups in the United States |journal=Archives of Internal Medicine |date=10 February 2003 |volume=163 |issue=3 |pages=286 |doi=10.1001/archinte.163.3.286 }}
* Fasano A, Berti I, Gerarduzzi T, et al. (2003). "Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study." ''Arch Intern Med''. 163 (3): 286–292. DOI: https://doi.org/10.1001/archinte.163.3.286.
* Hill ID, Dirks MH, Liptak GS, et al. (2005). "Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition." ''J Pediatr Gastroenterol Nutr''. 40 (1): 1–19. https://journals.lww.com/jpgn/Fulltext/2005/01000/Guideline_for_the_Diagnosis_and_Treatment_of.1.aspx
* {{cite journal |last1=Hill |first1=Ivor D. |last2=Dirks |first2=Martha H. |last3=Liptak |first3=Gregory S. |last4=Colletti |first4=Richard B. |last5=Fasano |first5=Alessio |last6=Guandalini |first6=Stefano |last7=Hoffenberg |first7=Edward J. |last8=Horvath |first8=Karoly |last9=Murray |first9=Joseph A. |last10=Pivor |first10=Mitchell |last11=Seidman |first11=Ernest G. |title=Guideline for the Diagnosis and Treatment of Celiac Disease in Children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition |journal=Journal of Pediatric Gastroenterology and Nutrition |date=January 2005 |volume=40 |issue=1 |pages=1–19 |url=https://journals.lww.com/jpgn/Fulltext/2005/01000/Guideline_for_the_Diagnosis_and_Treatment_of.1.aspx }}
* Drago S, El Asmar R, Di Pierro M, et al. (2006). "Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines." ''Scand J Gastroenterol''. 41 (4): 408–419. https://pubmed.ncbi.nlm.nih.gov/16635908-gliadin-zonulin-and-gut-permeability-effects-on-celiac-and-non-celiac-intestinal-mucosa-and-intestinal-cell-lines/.
* {{cite journal |last1=Drago |first1=Sandro |last2=El Asmar |first2=Ramzi |last3=Di Pierro |first3=Mariarosaria |last4=Grazia Clemente |first4=Maria |last5=Sapone |first5=Amit Tripathi Anna |last6=Thakar |first6=Manjusha |last7=Iacono |first7=Giuseppe |last8=Carroccio |first8=Antonio |last9=D'Agate |first9=Cinzia |last10=Not |first10=Tarcisio |last11=Zampini |first11=Lucia |last12=Catassi |first12=Carlo |last13=Fasano |first13=Alessio |last14=Fasano |first14=A |title=Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines |journal=Scandinavian Journal of Gastroenterology |date=26 August 2009 |volume=41 |issue=4 |pages=408–419 |doi=10.1080/00365520500235334 |pmid=16635908 }}
* Catassi C, Fabiani E, Iacono G, et al. (2007). "A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease." ''Am J Clin Nutr''. 85 (1):160–166. https://doi.org/10.1093/ajcn/85.1.160
* {{cite journal |last1=Catassi |first1=Carlo |last2=Fabiani |first2=Elisabetta |last3=Iacono |first3=Giuseppe |last4=D'Agate |first4=Cinzia |last5=Francavilla |first5=Ruggiero |last6=Biagi |first6=Federico |last7=Volta |first7=Umberto |last8=Accomando |first8=Salvatore |last9=Picarelli |first9=Antonio |last10=De Vitis |first10=Italo |last11=Pianelli |first11=Giovanna |last12=Gesuita |first12=Rosaria |last13=Carle |first13=Flavia |last14=Mandolesi |first14=Alessandra |last15=Bearzi |first15=Italo |last16=Fasano |first16=Alessio |title=A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease |journal=The American Journal of Clinical Nutrition |date=January 2007 |volume=85 |issue=1 |pages=160–166 |doi=10.1093/ajcn/85.1.160 }}
* {{cite journal |last1=Fasano |first1=Alessio |title=Surprises from Celiac Disease |journal=Scientific American |date=August 2009 |volume=301 |issue=2 |pages=54–61 |doi=10.1038/scientificamerican0809-54 |pmid=19634568 }}
* Fasano A. (2009). "Surprises from celiac disease." ''Sci Am''. 301 (2): 54–61. https://pubmed.ncbi.nlm.nih.gov/19634568-surprises-from-celiac-disease/
* Fasano A. (2012). "Zonulin, regulation of tight junctions, and autoimmune diseases." ''Annals of the New York Academy of Sciences'', ''1258'' (1), 25–33. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384703/
* {{cite journal |last1=Fasano |first1=Alessio |title=Zonulin, regulation of tight junctions, and autoimmune diseases |journal=Annals of the New York Academy of Sciences |date=2012 |volume=1258 |issue=1 |pages=25–33 |doi=10.1111/j.1749-6632.2012.06538.x |pmc=3384703 }}
* Sapone A, Lammers KM, Casolaro V, et al. (2011). "Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity." ''BMC Med''. 9(23). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065425/
* {{cite journal |last1=Sapone |first1=Anna |last2=Lammers |first2=Karen M |last3=Casolaro |first3=Vincenzo |last4=Cammarota |first4=Marcella |last5=Giuliano |first5=Maria Teresa |last6=De Rosa |first6=Mario |last7=Stefanile |first7=Rosita |last8=Mazzarella |first8=Giuseppe |last9=Tolone |first9=Carlo |last10=Russo |first10=Maria Itria |last11=Esposito |first11=Pasquale |last12=Ferraraccio |first12=Franca |last13=Cartenì |first13=Maria |last14=Riegler |first14=Gabriele |last15=de Magistris |first15=Laura |last16=Fasano |first16=Alessio |title=Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity |journal=BMC Medicine |date=9 March 2011 |volume=9 |pages=23 |doi=10.1186/1741-7015-9-23 |pmc=3065425 }}

== References ==
{{reflist}}


== External Links ==
== External Links ==
[[Harvard Medical School]] https://hms.harvard.edu/
*[[Harvard Medical School]] https://hms.harvard.edu/
*[[Harvard T.H. Chan School of Public Health]] https://www.hsph.harvard.edu/
*Center for Celiac Research and Treatment https://www.massgeneral.org/children/celiac-disease
*MassGeneral Hospital for Children https://www.massgeneral.org/children
*Harvard Medical School Celiac Research Program https://hms.harvard.edu/departments/hms-celiac-research-program
*Mucosal Immunology and Biology Research Center https://www.massgeneral.org/children/mucosal-immunology
*European Biomedical Research Institute of Salerno https://www.ebris.eu/home-english
*[[University of Naples Federico II|University of Naples]] School of Medicine https://www.italymedicalschools.com/university-of-napoli-federico-ii/
*[[University of Maryland School of Medicine]] https://www.medschool.umaryland.edu/
*[[Massachusetts General Hospital]] https://www.massgeneral.org/


{{Authority control}}
[[Harvard T.H. Chan School of Public Health]] https://www.hsph.harvard.edu/

Center for Celiac Research and Treatment https://www.massgeneral.org/children/celiac-disease

MassGeneral Hospital for Children https://www.massgeneral.org/children

Harvard Medical School Celiac Research Program https://hms.harvard.edu/departments/hms-celiac-research-program

Mucosal Immunology and Biology Research Center https://www.massgeneral.org/children/mucosal-immunology

European Biomedical Research Institute of Salerno https://www.ebris.eu/home-english

[[University of Naples Federico II|University of Naples]] School of Medicine https://www.italymedicalschools.com/university-of-napoli-federico-ii/

[[University of Maryland School of Medicine]] https://www.medschool.umaryland.edu/

[[Massachusetts General Hospital]] https://www.massgeneral.org/

== References ==
<br />{{Authority control}}


{{DEFAULTSORT:Fasano, Alessio}}
{{DEFAULTSORT:Fasano, Alessio}}

Revision as of 15:08, 3 March 2020


Alessio Fasano is an Italian-born medical doctor, pediatric gastroenterologist and researcher. He currently holds many roles, including professor of pediatrics at Harvard Medical School and professor of nutrition at Harvard T.H. Chan School of Public Health, both in Boston. He serves as director of the Center for Celiac Research and Treatment at MassGeneral Hospital for Children (MGHfC) and co-director of the Harvard Medical School Celiac Research Program. In addition, he is director of the Mucosal Immunology and Biology Research Center at MGHfC, where he oversees a research program with approximately 50 scientists and staff researching a variety of acute and chronic inflammatory diseases[1], including cystic fibrosis, celiac disease, enteric infections and necrotizing enterocolitis. A common theme of these programs is the study of the emerging role of the gut microbiome in health and disease. Dr. Fasano is also the scientific director of the European Biomedical Research Institute of Salerno (EBRIS) in Italy. Along with these leadership positions, he is a practicing outpatient clinician in pediatric gastroenterology and nutrition and the division chief.

Education

After graduating summa cum laude from the University of Naples School of Medicine in Italy (medicine and surgery), Fasano undertook intensive medical internships and residency in pediatrics, emergency medicine, and pediatric social medicine. After completing his final internship in 1993, he joined the faculty of the University of Maryland School of Medicine in Baltimore, MD as an associate professor, became a professor of pediatrics, medicine, and physiology in 1996, and remained in teaching roles at the university for over 20 years. He founded the Center for Celiac Research in 1996, which he moved to Massachusetts General Hospital in 2003. He is still an active professor of pediatrics and nutrition.

Work

Fasano began his career as a pediatric gastroenterologist interested in treating debilitating diarrhea, as well as a researcher determined to find a vaccine for cholera[2]. He was responsible for the discovery of several new enterotoxins involved in the diarrheal pathogenesis of several pathogens, including Shigella, E. coli, and V. cholerae. These discoveries led to the engineering of attenuated enteric vaccines, some of them currently used in clinical practice.

The course of this research path eventually led him and his team to the “serendipitous” discovery of zonulin in 2000, a protein responsible for regulating intestinal tight-junctions (and the over secretion of which causes “leaky-gut”). His major research focus then shifted to the study of intestinal permeability, the pathophysiology of the paracellular pathway, and how disruption of gut barrier function factors into chronic inflammatory disease development[3].

His current research focuses include intestinal mucosal biology and immunology, the gut microbiome, and bacterial pathogenesis, as well as the immune host response[4]. His clinical specialty lays in gluten-related disorders (celiac disease, wheat allergy, non-celiac gluten sensitivity) as well as other autoimmune and inflammatory disorders (diabetes mellitus type 1, autism, schizophrenia, and others).

Ultimately, Fasano is a dedicated physician who aspires to improve the quality of life for patients affected by disorders around the biological and immune functions of the intestinal mucosa.

Impact

Fasano is considered an expert and pioneering researcher worldwide in the field of celiac disease and bacterial pathogenesis. Not only did he found the premier celiac research center in the United States, but the impact of his more than 300 peer-reviewed journal publications and 160 patents has greatly shaped and advanced the knowledge of a multitude of chronic inflammatory diseases and immune diseases.

Throughout his career, he has prioritized and advocated for his patients by disseminating his research to the general public along with expansive outreach efforts. He often collaborates with celiac support organizations and government agencies to work toward this goal, and actively participates in fundraising efforts for the Center for Celiac Research and Treatment. He is the author of multiple books and has been featured in journals, magazines and interviews for the general public[5].

He has published numerous groundbreaking research studies, including the 2000 discovery of the zonulin protein and its regulation and modulation of intestinal permeability[6]. In 2003, he published the results of the epidemiological study that demonstrated the prevalence of celiac disease in the U.S. to be far higher than previously thought, at a rate of 1 in 133 persons.[7] His work also contributed to the development of an anti-tissue transglutaminase (tTG) diagnostic test for celiac disease, that is part of standard diagnostic testing for celiac disease.[8]

Awards

Fasano has received several awards for his work. Some notable awards include:  

1998, 2002, 2003 Teacher of the Year University of Maryland School of Medicine, Baltimore, MD Teaching
2004 Physician Hero, Health Care Hero Award The Daily Record, Baltimore, MD Health care
2006 Innovator of the Year The Daily Record, Baltimore, MD Research
2006 Best Academic/Industry Collaboration, Bioscience Award Greater Baltimore Committee, Baltimore, MD Translational science
2006 Entrepreneur of the Year Award University of Maryland, Baltimore, Baltimore, MD Translating science to business
2008 Magister Insignis La Nuova Scuola Medica Salernitana, Salerno, Italy Excellence in clinical and translational research
2009 President’s Faculty Research Lecturer of the Year Award University of Maryland, Baltimore, Baltimore, MD Top researcher of the year
2010 Arnold Silverman, M.D. Lectureship in Pediatric Gastroenterology, Hepatology, and Nutrition University of Colorado, Denver, CO Research and clinical care
2011 Kopelman Lecture Canadian Association of Gastroenterology, Oakville, Ontario, Canada Research
2012 Harry Shwachman Award North American Society of Pediatric Gastroenterology, Hepatology and Nutrition, Flourtown, PA Major lifelong scientific and/or educational contributions to the field of pediatric gastro-enterology, hepatology and nutrition in North America
2013 Linus Pauling Award for Functional Medicine The Institute for Functional Medicine, Federal Way, WA Visionary scientific contributions
2013 International Award Scuola Medica Salernitana Salerno Medical School, Salerno, Italy Visionary scientific contributions
2014 Paul Harris Fellow Rotary Foundation, Rotary International, Salerno, Italy Significant contributions in research and promoting international cooperation
2015 W. Allan Walker, MD Endowed Chair Massachusetts General Hospital Pediatric service in the Gastroenterology and Nutrition Division
2019 Traveling Genius Award Giordano Bruno Guerri, president and general director of the Fondazione il Vittoriale degli Italiani Significant scientific contributions over several decades

Book Publications

  • Fast Facts. Celiac Disease. By Fasano A, Holmes G, Catassi C. Oxford: Health Press, 2009.
  • Gluten Freedom. By Fasano A, Flaherty S. Wiley, 2014.
  • Senza glutine. La celiachia non si cura, si gestisce (in Italian). By Fasano A. Mondadori, 2017.
  • Se libérer du gluten: Le guide référence de la sensibilité au gluten et de la maladie coeliaque (Essai-Santé) (French Edition). By Fasano A. Marabout, 2017.
  • A Clinical Guide to Gluten-Related Disorders Paperback. By Fasano A. LWW, 2013.
  • Frontiers in Celiac Disease. By Fasano A, Troncone R, Branski D, eds. S. Karger Publishers, 2008.
  • From Ptolemaus to Copernicus: The Evolving System of Gluten-Related Disorder. By Catassi C, Fasano A. Mdpi AG, 2018.
  • Dieta Sem Glúten - Um Guia Essencial Para Uma Vida Saudável (in Portuguese). By Fasano A, Flaherty S, Rocha B. Madras, 2015.

Journal Publications

Fasano has authored (or co-authored) over 300 peer-reviewed publications. Some high-impact publications include:

  • Fasano, Alessio; Not, Tarcisio; Wang, Wenle; Uzzau, Sergio; Berti, Irene; Tommasini, Alberto; Goldblum, Simeon E (April 2000). "Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease". The Lancet. 355 (9214): 1518–1519. doi:10.1016/S0140-6736(00)02169-3.
  • Fasano, Alessio; Catassi, Carlo (February 2001). "Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum". Gastroenterology. 120 (3): 636–651. doi:10.1053/gast.2001.22123.
  • Fasano, Alessio; Berti, Irene; Gerarduzzi, Tania; Not, Tarcisio; Colletti, Richard B.; Drago, Sandro; Elitsur, Yoram; Green, Peter H. R.; Guandalini, Stefano; Hill, Ivor D.; Pietzak, Michelle; Ventura, Alessandro; Thorpe, Mary; Kryszak, Debbie; Fornaroli, Fabiola; Wasserman, Steven S.; Murray, Joseph A.; Horvath, Karoly (10 February 2003). "Prevalence of Celiac Disease in At-Risk and Not-At-Risk Groups in the United States". Archives of Internal Medicine. 163 (3): 286. doi:10.1001/archinte.163.3.286.
  • Hill, Ivor D.; Dirks, Martha H.; Liptak, Gregory S.; Colletti, Richard B.; Fasano, Alessio; Guandalini, Stefano; Hoffenberg, Edward J.; Horvath, Karoly; Murray, Joseph A.; Pivor, Mitchell; Seidman, Ernest G. (January 2005). "Guideline for the Diagnosis and Treatment of Celiac Disease in Children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition". Journal of Pediatric Gastroenterology and Nutrition. 40 (1): 1–19.
  • Drago, Sandro; El Asmar, Ramzi; Di Pierro, Mariarosaria; Grazia Clemente, Maria; Sapone, Amit Tripathi Anna; Thakar, Manjusha; Iacono, Giuseppe; Carroccio, Antonio; D'Agate, Cinzia; Not, Tarcisio; Zampini, Lucia; Catassi, Carlo; Fasano, Alessio; Fasano, A (26 August 2009). "Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines". Scandinavian Journal of Gastroenterology. 41 (4): 408–419. doi:10.1080/00365520500235334. PMID 16635908.
  • Catassi, Carlo; Fabiani, Elisabetta; Iacono, Giuseppe; D'Agate, Cinzia; Francavilla, Ruggiero; Biagi, Federico; Volta, Umberto; Accomando, Salvatore; Picarelli, Antonio; De Vitis, Italo; Pianelli, Giovanna; Gesuita, Rosaria; Carle, Flavia; Mandolesi, Alessandra; Bearzi, Italo; Fasano, Alessio (January 2007). "A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease". The American Journal of Clinical Nutrition. 85 (1): 160–166. doi:10.1093/ajcn/85.1.160.
  • Fasano, Alessio (August 2009). "Surprises from Celiac Disease". Scientific American. 301 (2): 54–61. doi:10.1038/scientificamerican0809-54. PMID 19634568.
  • Fasano, Alessio (2012). "Zonulin, regulation of tight junctions, and autoimmune diseases". Annals of the New York Academy of Sciences. 1258 (1): 25–33. doi:10.1111/j.1749-6632.2012.06538.x. PMC 3384703.
  • Sapone, Anna; Lammers, Karen M; Casolaro, Vincenzo; Cammarota, Marcella; Giuliano, Maria Teresa; De Rosa, Mario; Stefanile, Rosita; Mazzarella, Giuseppe; Tolone, Carlo; Russo, Maria Itria; Esposito, Pasquale; Ferraraccio, Franca; Cartenì, Maria; Riegler, Gabriele; de Magistris, Laura; Fasano, Alessio (9 March 2011). "Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity". BMC Medicine. 9: 23. doi:10.1186/1741-7015-9-23. PMC 3065425.{{cite journal}}: CS1 maint: unflagged free DOI (link)

References

  1. ^ "Mucosal Immunology and Biology Research Center". Massachusetts General Hospital. Retrieved 2020-03-02.
  2. ^ "Fasano Laboratory: Alessio Fasano, MD". Massachusetts General Hospital. Retrieved 2020-03-02.
  3. ^ "Fasano Laboratory: Alessio Fasano, MD". Massachusetts General Hospital. Retrieved 2020-03-02.
  4. ^ "Fasano Laboratory: Alessio Fasano, MD". Massachusetts General Hospital. Retrieved 2020-03-02.
  5. ^ "People". hms.harvard.edu. Retrieved 2020-03-02.
  6. ^ Fasano, Alessio; Not, Tarcisio; Wang, Wenle; Uzzau, Sergio; Berti, Irene; Tommasini, Alberto; Goldblum, Simeon E (2000-04-29). "Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease". The Lancet. 355 (9214): 1518–1519. doi:10.1016/S0140-6736(00)02169-3. ISSN 0140-6736.
  7. ^ Fasano, Alessio; Berti, Irene; Gerarduzzi, Tania; Not, Tarcisio; Colletti, Richard B.; Drago, Sandro; Elitsur, Yoram; Green, Peter H. R.; Guandalini, Stefano; Hill, Ivor D.; Pietzak, Michelle; Ventura, Alessandro; Thorpe, Mary; Kryszak, Debbie; Fornaroli, Fabiola; Wasserman, Steven S.; Murray, Joseph A.; Horvath, Karoly (10 February 2003). "Prevalence of Celiac Disease in At-Risk and Not-At-Risk Groups in the United States". Archives of Internal Medicine. 163 (3): 286. doi:10.1001/archinte.163.3.286. PMID 12578508.
  8. ^ "People". hms.harvard.edu. Retrieved 2020-03-02.

External Links